Home
Orbimed Advisors reported a 5.4% stake in CytomX Therapeutics CTMX · 8,461,500 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.4%
- Last report
- First report
- Shares held
- 8,461,500 sh
- Class
- Common Stock, par value $0.00001 per share
- Holder
- Orbimed Advisors
- Event date
- 25/06/30
- Filed
- 25/08/14
First 5%+ report · 5.4% stake
CytomX Therapeutics trades, last 26 weeks
What else happened in CytomX Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeADARx Pharmaceuticals
5% stakeADARx Pharmaceuticals
ADRX
14% stake
14,913,764 sh
14% stake
Filed 10/02
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
